DENTSPLY SIRONA (XRAY) Expected to Post Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is projected to announce its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to announce earnings of $0.3088 per share and revenue of $861.68 million for the quarter. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Parties can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the firm earned $0.52 EPS. On average, analysts expect DENTSPLY SIRONA to post $1.39 EPS for the current fiscal year and $1.48 EPS for the next fiscal year.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $9.73 on Wednesday. The stock has a market cap of $1.94 billion, a P/E ratio of 6.92, a PEG ratio of 1.27 and a beta of 0.87. The company’s 50-day simple moving average is $9.66 and its 200 day simple moving average is $11.31. DENTSPLY SIRONA has a twelve month low of $8.32 and a twelve month high of $14.76. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 26th. BMO Capital Markets lowered their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research note on Thursday, September 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday. Barclays increased their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a report on Monday, August 24th. Finally, Piper Sandler cut their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, October 9th. Three investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $12.62.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.